Cassava Sciences
SAVA
#9221
Rank
A$0.15 B
Marketcap
A$3.29
Share price
-23.68%
Change (1 day)
-10.48%
Change (1 year)

Earnings for Cassava Sciences (SAVA)

Earnings in 2025 (TTM): -A$0.18 Billion

According to Cassava Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$0.22 Billion a decrease over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cassava Sciences from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.18 Billion-18.61%
2024 -A$0.22 Billion34.28%
2023 -A$0.17 Billion32.41%
2022 -A$0.13 Billion143.46%
2021 -A$49.7 Million383.92%
2020 -A$10.27 Million36.96%
2019 -A$7.5 Million-25.56%
2018 -A$10.08 Million-44.25%
2017 -A$18.07 Million-20.11%
2016 -A$22.62 Million5.32%
2015 -A$21.48 Million14.23%
2014 -A$18.8 Million-139.64%
2013 A$47.42 M
2010 -A$20.72 Million102.87%
2009 -A$10.22 Million-177.52%
2008 A$13.17 M-14.32%
2007 A$15.37 M-1942.21%
2006 -A$0.84 Million
2004 -A$58.91 Million75.1%
2003 -A$33.65 Million
2001 -A$26.18 Million20.49%
2000 -A$21.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion 31.98%๐Ÿ‡บ๐Ÿ‡ธ USA